Expert Q&A: Key Issues and Developments in Clinical Lab Automation
Laboratory leaders from Geisinger discuss key lab automation developments in their organization.
Laboratory leaders from Geisinger discuss key lab automation developments in their organization.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Liron Pantanowitz, MD, PhD, discusses the key issues pathologists face today, and how technology could help.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.